ESEM24

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population.

Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are represented at Cleveland Clinic Abu Dhabi.

The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world-class facilities across 24 clinical departments that include a range of cancer subspecialities and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.

Cleveland Clinic Abu Dhabi provides patients in the region direct access to world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world-class service standards, closer to home.

Better Health, Brighter Future

Takeda is a global, R&D-driven biopharmaceutical company committed to discovering and delivering life-transforming treatments and vaccines that have a lasting impact on society.

Since our founding in 1781 in a market stall in Osaka, Japan, our values endure by putting patient needs first, building trust with society, strengthening our reputation, and developing the business - in that order.

At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love. Founded in Chicago 135 years ago, Abbott is currently serving people in more than 160 countries with leading medical devices, diagnostics, nutrition products and branded generic medicines. Our 115,000 colleagues are helping millions of people to live better and healthier.

GE HealthCare (Nasdaq: GEHC) is a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across the care pathway.

MEAD Medical Supplies & Equipment LLC

The leading provider of emergency and diagnostic medical solutions for the hospital and pre-hospital markets in the United Arab Emirates

Who We Are

Established in 2016, MEAD Medical is a fast-growing medical distribution company within the United Arab Emirates, focusing on providing the healthcare sector with new, innovative and exciting medical solutions.

Our aim is to significantly reduce the pressures faced by healthcare practitioners in treating patients, to ensure the highest levels of quality care all over the UAE.

Our solutions will provide that ‘wow’ factor that will enable us to achieve our aim and satisfy our clients within the near and long term.

SERB Pharmaceuticals is a global specialty pharmaceutical company focused on addressing critical care and life-threatening conditions. With a commitment to saving lives and improving patient outcomes, SERB has established itself as a leader in the field of emergency care and rare diseases, offering a diverse portfolio of innovative products.

The company specializes in providing niche, high-value treatments for areas where immediate and effective solutions are paramount. Key therapeutic focuses include Emergency, toxicology, neurology, and rare metabolic disorders. SERB’s flagship products are vital in treating conditions such as cyanide poisoning, severe metal poisoning and hematological and oncological emergencies.

Operating in over 50 countries, SERB collaborates closely with healthcare providers, emergency responders, and government agencies to ensure the availability of critical treatments in urgent situations. The company’s strategic partnerships and investments in research and development enable it to maintain a robust pipeline of life-saving products.

At the core of SERB’s mission is a dedication to quality, innovation, and patient-centric care. By addressing unmet medical needs in critical and emergency care, SERB Pharmaceuticals continues to make a significant impact in the healthcare sector, ensuring that the most vulnerable patients receive timely and effective treatment when it matters most.

GulfDrug LLC is a dynamic, multifaceted organization with an established reputation as the leading end-to-end healthcare solutions provider. Founded by the late Dr. Hassan Al Moosa in 1969, his enduring vision was to deliver the finest available medical care by sourcing state of the art Medical Equipment. Dr. Hassan sadly passed away in 1996 but in doing so, left behind an enduring legacy for GulfDrug LLC, and the Al Moosa family. The company retains a focused and unwavering commitment to develop outstanding medical services across its valued customer base and strategic partners. Today the company flourishes thanks to the astute management team of Dr. Zeyad Al Moosa, a U.S educated pharmacist, and Mr. Rashad Al Moosa, a graduate of finance. Together they have worked tirelessly to ensure the continuation of the legacy, core values, and principles set out by the company's founding father.

Mission
To create and provide reliable quality and value for our customers, partners and stakeholders, that will improve healthcare outcomes and services.

Vision
To be the customer’s preferred provider of products, services and solutions, to the selected segments of the healthcare industry that we serve.

Gulf Med Medicine LLC. is a subsidiary company of Gulf Drug LLC providing sales and Marketing for a Healthcare Business Partners through a very Ambitious and Professional Team. We are present in multiple branches in the Middle East, providing regional business at a multinational standard. We have more than 150 employees across the GCC, Egypt and Iraq. And as a dynamic organization with high capability of building new lines through its dedicated teams and focus on market intelligence.

MissionOur Mission is to bring innovation and sincerity to medical services and to provide reliable quality and value for our customers and stakeholders. That’s because our Vision is to be the customer's preferred provider of products, services, and solutions to the selected segments of the healthcare industry that we serve.

Since 2009 Leader Healthcare has rapidly grown to become one of the largest and most influential names in healthcare solutions across the Middle East. Based in Dubai, and with offices in India and Australia, we have an international approach to distributing only the best medical products, equipment and training to healthcare professionals.